David Irvine

2.0k total citations
40 papers, 1.1k citations indexed

About

David Irvine is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, David Irvine has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in David Irvine's work include Chronic Myeloid Leukemia Treatments (8 papers), CAR-T cell therapy research (6 papers) and Hedgehog Signaling Pathway Studies (5 papers). David Irvine is often cited by papers focused on Chronic Myeloid Leukemia Treatments (8 papers), CAR-T cell therapy research (6 papers) and Hedgehog Signaling Pathway Studies (5 papers). David Irvine collaborates with scholars based in United Kingdom, United States and Switzerland. David Irvine's co-authors include Mhairi Copland, David Gunnell, Richard M. Martin, Lauren A. Wise, Charlotte Aull Davies, Michael Bagshaw, Tessa L. Holyoake, Ravi Bhatia, Ian Douglas and Liam Smeeth and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

David Irvine

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Irvine United Kingdom	18	356	250	237	158	139	40	1.1k
Yoko Tanaka Japan	23	402 1.1×	313 1.3×	109 0.5×	84 0.5×	223 1.6×	107	1.5k
Joachim Kreuder Germany	19	508 1.4×	71 0.3×	120 0.5×	105 0.7×	231 1.7×	53	1.4k
Mark Juckett United States	20	557 1.6×	305 1.2×	666 2.8×	74 0.5×	96 0.7×	73	1.5k
Mark Ross United Kingdom	20	372 1.0×	188 0.8×	97 0.4×	119 0.8×	111 0.8×	43	1.1k
Nan Jin China	17	503 1.4×	202 0.8×	62 0.3×	42 0.3×	70 0.5×	53	1.4k
Yvonne Baumer United States	22	589 1.7×	194 0.8×	69 0.3×	198 1.3×	77 0.6×	64	1.7k
Angela Chetrit Israel	16	200 0.6×	97 0.4×	64 0.3×	70 0.4×	55 0.4×	30	880
Laurent Grange France	20	228 0.6×	102 0.4×	127 0.5×	133 0.8×	28 0.2×	67	1.2k
Alissa Huston United States	16	297 0.8×	326 1.3×	274 1.2×	61 0.4×	173 1.2×	47	1.0k
Thomas D. Ryan United States	20	238 0.7×	233 0.9×	112 0.5×	86 0.5×	117 0.8×	101	1.6k

Countries citing papers authored by David Irvine

Since Specialization

Citations

This map shows the geographic impact of David Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Irvine more than expected).

Fields of papers citing papers by David Irvine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Irvine. The network helps show where David Irvine may publish in the future.

Co-authorship network of co-authors of David Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of David Irvine. A scholar is included among the top collaborators of David Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Irvine. David Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Irvine, David, et al.. (2024). Comparative autofluorescence analysis of silicon nitride and tantalum pentoxide waveguides at 532 nm. Optics Express. 33(1). 543–543.

Roddie, Claire, Lorna Neill, Wendy Osborne, et al.. (2023). Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma. Blood Advances. 7(12). 2872–2883. 64 indexed citations

Irvine, David, et al.. (2023). Direct Comparison of the Autofluorescence of Silicon Nitride and Tantalum Pentoxide Waveguides at 532 nm. JTu4A.81–JTu4A.81. 1 indexed citations

Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2020). Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia. 34(7). 1975–1975. 1 indexed citations

Kinstrie, Ross, Gillian A. Horne, Heather Morrison, et al.. (2020). CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia. 34(6). 1613–1625. 50 indexed citations

Irvine, David, Graham Macdonald, Grant McQuaker, et al.. (2018). High-Dose Chemotherapy in Relapsed or Refractory Metastatic Germ-Cell Cancer: The Scotland Experience. Clinical Genitourinary Cancer. 17(2). 125–131. 3 indexed citations

Irvine, David, Bin Zhang, Ross Kinstrie, et al.. (2016). Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Scientific Reports. 6(1). 25476–25476. 58 indexed citations

Flis, Krzysztof, David Irvine, Mhairi Copland, Ravi Bhatia, & Tomasz Skórski. (2012). Chronic myeloid leukemia stem cells display alterations in expression of genes involved in oxidative phosphorylation. Leukemia & lymphoma. 53(12). 2474–2478. 25 indexed citations

Douglas, Ian, Liam Smeeth, & David Irvine. (2010). The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. British Journal of Clinical Pharmacology. 71(1). 116–120. 35 indexed citations

10.

Irvine, David, et al.. (2009). Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors – A synthesis of clinical and laboratory data. Blood Reviews. 24(1). 1–9. 10 indexed citations

11.

Gunnell, David, David Irvine, Lauren A. Wise, Charlotte Aull Davies, & Richard M. Martin. (2009). Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. BMJ. 339(oct01 1). b3805–b3805. 146 indexed citations

12.

Marx, Randall B., et al.. (2005). Analysis of VX nerve agent hydrolysis products in wastewater effluents by ion chromatography with amperometric and conductivity detection. Journal of Chromatography A. 1089(1-2). 65–71. 31 indexed citations

13.

Irvine, David. (2004). The Human Rights Act: Principle and Practice. Parliamentary Affairs. 57(4). 744–753. 1 indexed citations

14.

Blettner, Maria, Hajo Zeeb, Anssi Auvinen, et al.. (2003). Mortality from cancer and other causes among male airline cockpit crew in Europe. International Journal of Cancer. 106(6). 946–952. 71 indexed citations

15.

Irvine, David, et al.. (1999). British Airways flightdeck mortality study, 1950-1992.. PubMed. 70(6). 548–55. 60 indexed citations

16.

Irvine, David, et al.. (1998). Comparison of carprofen and pethidine as postoperative analgesics in the cat. Journal of Small Animal Practice. 39(4). 158–164. 54 indexed citations

17.

Irvine, David, et al.. (1993). A Study of Thorium Exposure during Tungsten Inert Gas Welding in an Airline Engineering Population. Journal of Occupational and Environmental Medicine. 35(7). 707–711. 1 indexed citations

18.

Ashworth, J., et al.. (1993). Irritant contact dermatitis in warehouse employees. Occupational Medicine. 43(1). 32–34. 5 indexed citations

19.

Irvine, David, et al.. (1992). The mortality of British Airways pilots, 1966-1989: a proportional mortality study.. PubMed. 63(4). 276–9. 35 indexed citations

20.

PRYCE, D.W., David Irvine, John English, & R. J. G. Rycroft. (1989). Soluble oil dermatitis: a follow‐up study. Contact Dermatitis. 21(1). 28–35. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact